首页> 外文会议>AIChE Annual Meeting >M2e Ligated to Elastin like Polypeptide Induces Protective Immunity Against Influenza A Virus
【24h】

M2e Ligated to Elastin like Polypeptide Induces Protective Immunity Against Influenza A Virus

机译:将M2E连接到Elastin,如多肽,诱导对甲型流感病毒的保护性免疫力

获取原文

摘要

With seasonal influenza epidemics leading to remarkable mortality and morbidity throughout the globe, and posing a continuous threat of another pandemic, the influenza virus is considered one of the most deadly human pathogen. In contrast to current vaccines, which are based on the two dominant influenza virus surface glycoproteins - hemagglutinin (HA) and neuraminidase (NA), recent effort has been devoted towards development of a universal influenza vaccine based on the highly conserved sequence of the extracellular region of an influenza membrane protein called M2e. An M2e-based vaccine could offer broader protection against different influenza strains, in contrast to the narrow protection provided by HA and NA-based vaccines. Research done in the past has shown that immunogenicity of M2e can be greatly enhanced by linking M2e, a comparatively smaller antigen, to an appropriate carrier. With this in mind, we wanted to investigate the use of elastin-like polypeptides (ELPs) as an approach to enhance the immunogenicity of M2e. ELPs contain a repeat sequence of ?GXGVP', where 'X' can be any amino acid except proline, and have been shown to be biocompatible and biodegradable in nature. ELPs also exhibit an inverse transition behaviour wherein they precipitate above a certain critical temperature. Thus we hypothesized that M2e-ELPs when designed to precipitate below the body temperature could provide a particulate stimulus to the immune system, and might offer a better alternative to certain carriers such as human papillomavirus, hepatitis B virus core subunit, and keyhole limpet hemocyanin.
机译:随着季节性流感流行病,导致全球性卓越的死亡率和发病率,并对这种大流行的持续威胁,流感病毒被认为是最致命的人类病原体之一。与基于两个显性流感病毒表面糖蛋白(HA)和神经氨氨酸酶(NA)的目前的疫苗相比,最近努力致力于基于细胞外区域的高度保守序列的通用流感疫苗的发展一种称为M2e的流感膜蛋白。基于M2E的疫苗可以对不同的流感菌株提供更广泛的保护,与HA和Na基疫苗提供的狭窄保护相比。过去所做的研究表明,通过将M2E,相对较小的抗原连接到适当的载体,可以大大提高M2E的免疫原性。考虑到这一点,我们想调查使用Elastin样多肽(ELP)作为增强M2E免疫原性的方法。 ELP含有重复序列的αGXGVP',其中'x'可以是除脯氨酸外的任何氨基酸,并且已被证明是生物相容性和生物降解的性质。 ELP还表现出反转过渡行为,其中它们沉淀在某个临界温度之上。因此,我们假设M2E-ELP在设计下沉淀到体温以下时可以为免疫系统提供颗粒状刺激,并且可以为某些载体(如人乳头瘤病毒,乙型肝炎病毒核心亚基)和孔孔颗粒血晶素提供更好的替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号